Fatema Shafie Khorassani
Profiles

Fatema Shafie Khorassani, PhD

Assistant Professor, Biostatistics - Boston University School of Public Health

Biography

Professor Fatema Shafie Khorassani’s work focuses on data integration methods for time-to-event outcomes and on statistical methods for surrogate endpoints. Her collaborative projects focus on studying health disparities in cancer, substance abuse, and stroke. Prior to joining SPH, she completed her PhD in the Department of Biostatistics at the University of Michigan School of Public Health.

Education

  • University of Michigan at Ann Arbor, PhD Field of Study: Biostatistics
  • University of Michigan at Ann Arbor, MS Field of Study: Biostatistics
  • Wayne State University, MPH Field of Study: Biostatistics
  • Wayne State University, BS Field of Study: Mathematics

Publications

  • Published on 4/24/2023

    Shafie Khorassani F, Brouwer AF, Hirschtick JL, Jeon J, Jimenez-Mendoza E, Meza R, Fleischer NL. Patterns of poly tobacco use among adults in the Population Assessment of Tobacco and Health (PATH) study, 2013-2017: a multistate Markov transition analysis. Tob Control. 2023 Apr 24. PMID: 37094934.

    Read At: PubMed
  • Published on 4/11/2023

    Chen C, He K, Morgenstern LB, Shi X, Shafie-Khorassani F, Lisabeth LD. Trends and ethnic differences in stroke recurrence and mortality in a biethnic population, 2000-2019: a novel application of an illness-death model. Ann Epidemiol. 2023 Sep; 85:51-58.e5. PMID: 37054958.

    Read At: PubMed
  • Published on 2/9/2023

    Shafie-Khorassani F, Piper ME, Jorenby DE, Baker TB, Benowitz NL, Hayes-Birchler T, Meza R, Brouwer AF. Associations of Demographics, Dependence, and Biomarkers With Transitions in Tobacco Product Use in a Cohort of Cigarette Users and Dual Users of Cigarettes and E-cigarettes. Nicotine Tob Res. 2023 Feb 09; 25(3):462-469. PMID: 36037523.

    Read At: PubMed
  • Published on 1/1/2023

    Shafie-Khorassani F, Taylor JMG, Kaciroti N, Elliott MR. Incorporating covariates into measures of surrogate paradox risk. Stats. 2023; 6(1):322-344.

  • Published on 12/23/2020

    Lank RJ, Shafie-Khorassani F, Zhang X, Ortiz C, Kim S, Case E, Creutzfeldt CJ, Morgenstern LB, Zahuranec DB. Advance Care Planning and Transitions to Comfort Measures after Stroke. J Palliat Med. 2021 Aug; 24(8):1191-1196. PMID: 33370167.

    Read At: PubMed
  • Published on 7/23/2020

    Markovitz N, Morgenstern LB, Shafie-Khorassani F, Cornett BA, Kim S, Ortiz C, Lank RJ, Case E, Zahuranec DB. Family Perceptions of Quality of End-of-Life Care in Stroke. Palliat Med Rep. 2020; 1(1):129-134. PMID: 32856025.

    Read At: PubMed
  • Published on 7/16/2020

    Sozener CB, Lisabeth LD, Shafie-Khorassani F, Kim S, Zahuranec DB, Brown DL, Skolarus LE, Burke JF, Kerber KA, Meurer WJ, Case E, Morgenstern LB. Trends in Stroke Recurrence in Mexican Americans and Non-Hispanic Whites. Stroke. 2020 Aug; 51(8):2428-2434. PMID: 32673520.

    Read At: PubMed
  • Published on 6/10/2019

    Bailoor K, Shafie-Khorassani F, Lank RJ, Case E, Garcia NM, Lisabeth LD, Sánchez BN, Kim S, Morgenstern LB, Zahuranec DB. Time Trends in Race-Ethnic Differences in Do-Not-Resuscitate Orders After Stroke. Stroke. 2019 Jul; 50(7):1641-1647. PMID: 31177986.

    Read At: PubMed
  • Published on 5/27/2019

    Brown DL, Shafie-Khorassani F, Kim S, Chervin RD, Case E, Yadollahi A, Lisabeth LD. Do apneas and hypopneas best reflect risk for poor outcomes after stroke? Sleep Med. 2019 Nov; 63:14-17. PMID: 31600656.

    Read At: PubMed
  • Published on 5/14/2019

    Lank RJ, Lisabeth LD, Levine DA, Zahuranec DB, Kerber KA, Shafie-Khorassani F, Case E, Zuniga BG, Cooper GM, Brown DL, Morgenstern LB. Ethnic Differences in 90-Day Poststroke Medication Adherence. Stroke. 2019 Jun; 50(6):1519-1524. PMID: 31084331.

    Read At: PubMed

News & In the Media